XS
LLY icon

XR Securities’s Eli Lilly LLY Stock Holding History

XR Securities’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-2,900
Closed -$2.24M – 4
2024
Q4 		$2.24M Sell
2,900
-2,500
-46% -$2.07M 41.84% 1
2024
Q3 		$4.78M Hold
5,400
– – 1.4% 16
2024
Q2 		$4.89M Sell
5,400
-1,400
-21% -$1.12M 0.89% 21
2024
Q1 		$5.29M Sell
6,800
-500
-7% -$356K 0.17% 37
2023
Q4 		$4.26M Buy
7,300
+800
+12% +$467K 0.16% 52
2023
Q3 		$3.49M Buy
6,500
+3,300
+103% +$1.7M 0.27% 56
2023
Q2 		$1.5M Sell
3,200
-11,300
-78% -$4.74M 0.07% 115
2023
Q1 		$4.98M Buy
14,500
+12,400
+590% +$4.18M 0.13% 40
2022
Q4 		$768K Buy
+2,100
New +$745K 0.08% 201

Other funds holding LLY

PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

XR Securities's LLY Position: Q4 2024 in Review

XR Securities sold out of Eli Lilly (LLY) in Q4 2024, closing a stake of 285 shares — an estimated $236K sold.

XR Securities first reported a position in LLY in Q4 2018 and held it in 13 quarters. The position peaked at $2.72M in Q1 2023. 3,906 funds tracked by Wall St. Rank hold LLY as of Q4 2024.

  • XR Securities reported no remaining Eli Lilly position as of Q4 2024 after selling out during the quarter.
  • XR Securities sold 285 Eli Lilly shares in Q4 2024, an estimated $236K.
  • XR Securities first reported a position in Eli Lilly in Q4 2018 and held it in 13 quarters.
  • XR Securities's Eli Lilly position peaked at $2.72M in Q1 2023.
  • 3,906 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2024.

Based on XR Securities's 13F filing for Q4 2024, filed 17 Jan 2025.